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Abstract
Background:  Cardiac  resynchronization  therapy (CRT)  has  become an important  pillar  of 
contemporary heart failure therapy. The efficacy of CRT, however, critically relies on proper 
LV lead placement and performance, which is why data regarding the long-term performance 
of CS leads are of considerable interest. Available studies are limited by a restricted variety of 
lead vendors, earlier lead models and / or very short follow-up periods. In the current study, 
we therefore investigated  the long-term performance of  modern LV leads  in  a  large "real 
world"  cohort  of  patients  undergoing  CRT  implantation.                     
Methods and Results:  All 193 patients who had successfullyundergone CRT implantation at 
the University Hospital Zurich between September 2003 and January 2010 were included in 
the study. An overall  stable  course of stimulation  energy was observed over time;  neither 
ischemic  etiology,  lead  configuration,  or  severely  reduced  EF  had  an  influence  on  the 
evolution of energy thresholds over time. Interestingly, patients with a high energy threshold 
at baseline experienced a significant reduction during follow-up. In contrast, a significant drop 
in impedance was seen following implantation, followed by a steady course for the rest of the 
observation period. Only 15 patients (9.7%) showed an impedance > 1000 Ohm at any time 
during  their  follow-up.  Seven  lead  dislocations  were  observed  during  follow up.         
Conclusions:  The  current  comprehensive  analysis  of  long-term  performance  of  modern 
coronary sinus leads demonstrates excellent stability, performance and safety. These data may 
have important implications for physicians involved in biventricular pacemaker implantations 
and in the follow-up care of these patients.
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Introduction
Cardiac resynchronization  therapy (CRT) has become an important  pillar  of contemporary 
heart failure therapy due to the impressive reduction in morbidity and mortality observed in 
large-scale clinical trials  [1-3]. Several myocardial  diseases are associated with changes in 
cardiac  structure  and  function  resulting  in  regions  of  early  and  late  left  ventricular  (LV) 
contraction, ultimately leading to intra- and interventricular dyssynchrony and impaired left-
ventricular  contractile  function.  In  CRT,  biventricular  pacing  re-synchronizes  the  left 
ventriclevia an LV lead placed in a tributary of the coronary sinus (CS) in addition to the 
standard right atrial and right ventricular leads, resulting in an increase in cardiac output and 
reverse  left  ventricular  remodeling  [4].                                        
The  efficacy  of  biventricular  pacing  critically  relies  on  proper  LV  lead  placement  and 
performance. The former, however, is not infrequently challenging; indeed, lead placement at 
anatomically optimal sites for effective LV resynchronization sometimes requires accepting 
high capture thresholds due to suboptimal lead contact or presence of scar tissue. As such, the 
possibility of late lead failure due to rising thresholds, increased battery drain,and, eventually 
even loss of biventricular pacing is of concern. Data regarding the long-term performance of 
CS leads,  especially  in  relation  to  baseline  characteristics  at  the  time of  implantation,  are 
therefore of considerable interest. So far, few studies have investigated the behavior of LV 
leads  in  CRT patients;  moreover,  these series  were limited  by a restricted  variety  of lead 
vendors, earlier lead models and / or very short follow-up periods [5-10]. In the current study, 
we therefore investigated  the long-term performance of  modern LV leads  in  a  large "real 
world" cohort of patients undergoing CRT implantation.                                    
Methods
Study population  and CRT implantation  procedure                                   
All 193 patients who had undergone successful CRT implantation including placement of a 
coronary sinus left ventricular lead at the University Hospital Zurich between September 2003 
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and January 2010 were included in the study (patients implanted by J.H. and D.H.). Patients in 
whom transvenous LV lead placement was not possible as well as patients with epicardial LV 
leads were excluded from the study. For analyses of follow-up parameters, patient files at our 
pacemaker  clinic  were  reviewed.                                      
Biventricular  pacemakers  /  ICDs  and  leads  from  Biotronik,  Guidant  /  Boston  Scientific, 
Medtronic and St. Jude Medical were implanted (Table 1). The implantation procedure was 
performed  under  local  anaesthesia  using  standard  techniques.  For  implantation  of  the  left 
ventricular (LV) lead, the coronary sinus (CS) was intubated with a CS sheath, followed by a 
CS venogram to evaluate coronary vein anatomy. Implantation into a lateral or postero-lateral 
vein  in  the  midventricular  region  of  the  LV was  attempted  whenever  possible.  Real-time 
measurements  of  LV  lead  stimulation  threshold,  impedance  and  R-wave  sensing  was 
performed using a Medtronic analyzer system (Medtronic 8900, Medtronic Inc, Minneapolis 
MN, USA). The energy threshold required for reproducible successful LV capture is presented 
as stimulation energy derived from the following formula: E = V2 x t / R (E = energy [uJ]; V = 
voltage  [V];  t  =  stimulation  pulse  width  [s];  R =  impedance  [Ohm]).  Echocardiography, 
including  left  ventricular  scar  assessment  was  performed  according  to  standard  protocols 
(Philips iE33 or GE Vivid 7).
Table 1: Baseline characteristics at implantation
Continuous and categorical variables are presented as mean +/- standard deviation and number (%), respectively.
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Baseline  and  follow-up  measurements                                  
LV lead measurements at implantation were taken in the operating room following successful 
lead  placement.  Baseline  measurements  were  taken  prior  to  hospital  discharge  (one  day 
following device implantation in most patients). Further measurements were recorded when 
patients  presented  for  scheduled  follow-up  visits  to  our  pacemaker  clinic  or  in  case  of 
unplanned  consultations.                                     
Statistics
Statistical analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL) and GraphPad 
Prism  4.0  (GraphPad  Software,  San  Diego,  USA).  Unpaired  continuous  and  categorical 
variables  were  compared  using  Student's  t-test  and  Chi-square  test,  respectively. 
Intraindividual development of variables (energy threshold, impedance and sensing at baseline 
and follow-up) were compared using paired Student's t-test. Comparisons of > 2 groups were 
performed using an ANOVA test with Bonferroni correction in case of significant results. A p-
value  <  0.05  was  considered  significant.                                       
Results
Baseline  characteristics  and  follow-up                                         
Baseline clinical, echocardiographic and implantation characteristics are summarized in Table 
1.  Clinical  and  echocardiographic  findings  are  those  typical  of  a  cohort  of  patients  with 
chronic heart failure. Devices and leads from all four manufacturers were implanted; however, 
both leads and devices from Guidant / Boston Scientific were only used in a minority of cases.
Median follow-up of all patients with at least one follow-up visit at our center was 24 months. 
The evolution of coronary lead stimulation energy threshold, impedance and R-wave sensing 
is shown in Figure 1. For stimulation energy, an overall stable course was observed over time. 
In contrast,  a significant drop in impedanc was seen following implantation, followed by a 
steady course for the remainder of the observation period. Similarly, albeit to a lesser degree, a 
drop in the sensed R-wave amplitude occurred following implantation,  with no significant 
change over the ensuing months. 
Evolution  of  LV  lead  threshold                                        
Selected  subgroup  comparisons  of  energy  threshold,  impedance,  and  R-wave  sensing  at 
baseline (pre-discharge) and during follow-up (12-15 months) are shown in Table 2. In order 
to  perform a  valid  analysis,  only  patients  with  both  baseline  and  follow-up  values  were 
compared. No statistically significant differences in energy threshold, impedance or R-wave 
sensing were observed at  baseline and at  12 months follow-up when patients without pre-
discharge and follow-up measurements, respectively, were excluded (data not shown). 
Overall,  no significant  difference in  average  energy threshold was observed during 1-year 
follow-up  as  compared  to  baseline  (Table  2).  Neither  ischemic  etiology,  gender,lead 
configuration,  nor  severely  reduced  EF  had  an  influence  on  the  development  of  energy 
thresholds over time (data not shown). A marginally significant effect of the lead manufacturer 
most likely occurred as a result of chance due to the low number of leads implanted from one 
vendor.  Interestingly,  patients  with a high energy threshold at  baseline (defined as > 1μJ) 
experienced a significant reduction during follow-up; in contrast, those with a lower threshold 
at  baseline  demonstrated  a  rise  in  threshold  over  time.                           
Overall,  67 patients (35.4%) had a high LV lead threshold  at  implantation,   which  was 
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particularly prevalent in patients with an LV scar (20 / 38 patients, 53%; p=0.012 vs. no scar).  
During follow-up, 22% of patients (33/152) had a very high maximal LV threshold (defined as 
> 3μJ). Patients with a threshold > 1μJ at implantation had a higher chance of going on to a 
threshold ≥ 3μJ at any time during follow up as compared to patients with a threshold < 1μJ  
(34% vs. 16%, p=0.006).
Figure 1: Long-term development of left ventricular leads energy threshold (A), impedance (B) and sensing (C). 
Mean, standard deviation and range are shown.
Evolution  of  LV  lead  impedance                                            
During follow-up, no significant change in impedance from pre-discharge values was observed 
for the overall cohort (Tab. 2). As expected, impedance was higher in bipolar leads, which did 
not change during follow up. Also patients with a low EF (< 30%) demonstrated slightly lower 
LV  lead  impedance.  Other  baseline  characteristics  including  coronary  heart  disease, 
gender,lead  configuration,  and LV scar  did not  significantly  affect  LV lead  impedance  at 
baseline or at follow-up.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (3): 112-120 (2014)
Steffel J et al, “Long-Term Performance of Modern Coronary Sinus Leads in CRT”       117
Table 2: Energy threshold, impedance and R-wave sensing at baseline (pre-discharge) and at 
12 (-15) months follow up of the entire cohort and for selected subgroups. 
Data are presented as mean +/- standard deviation. n.s. = not significant.
Patients  with  impedance  values>  1000  Ohm  at  the  time  of  implantation  experienced  a 
significant drop until the time of hospital discharge (Figure 1). Indeed, only 28% of patients 
with an impedance > 1000 Ohm at implantation still had a high impedance at pre-discharge, 
while  it  had normalized  in the remaining 72% (data  not shown).  Only 15 patients  (9.7%) 
showed  an  impedance  >  1000  Ohm  at  any  time  during  their  follow-up;  no  baseline 
characteristics, including a high impedance after implantation, was more frequently found in 
this  subgroup  of  patients.                                     
Evolution  of  LV  lead  R-wave  sensing                                      
On average, left ventricular R-wave sensing improved slightly during follow up (11.5 +/- 6.3 
mV vs. 13.5 +/- 6.2 mV, p=0.007). This was particularly pronounced in patients with non-
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ischemic heart disease, in those with a bipolar lead, and in those with no scar or a scar outside  
the prime target region for LV lead placement (while patients with a scar in the lateral  or 
posterior LV segments experienced a decrease in R-wave sensing over time).                   
Lead  Dislocations                                              
A total of 7 cases of LV-lead dislocations (3.6%) were observed during follow-up. The median 
time to dislocation was 111 days (range 10 - 283 days). Six cases were macro-dislocations 
necessitating lead revision. In one case a micro-dislocation leading to considerably elevated 
stimulation thresholds was observed, which was managed conservatively (i.e., without re-do 
operation).  No significant  adverse events,  including arrhythmic events,  were observed as a 
result  of  dislocated  leads.                                        
Discussion
Optimal lead placement is of paramount importance for a favorable outcome in CRT [11]. 
Indeed, suboptimal lead positioning may be one of the key factors involved in the lack of 
response to  CRT,  which  can  be observed in  as  many as  30% of  CRT recipients  [11-13]. 
Implantation into a lateral or postero-lateral vein is therefore attempted whenever possible, as 
this  has  been  associated  with  the  highest  likelihood  of  clinical  and  echocardiographic 
improvement [4]. However, high LV capture thresholds as well as high impedance values are 
not infrequently encountered at those otherwise optimal sites. In these situations, considerable 
uncertainty regarding the future behavior of these leads is imminent during implantation. As a 
result, a well-suited LV pacing site may be abandoned for another, potentially less suitable 
position  in  order  to  achieve  a  lower  energy  threshold  or  impedance.                
Our current comprehensive analysis of the long-term behavior of modern coronary sinus leads 
provides several findings which may be of value for physicians implanting and/or managing 
patients with CRT devices. We demonstrate that most patients with a high energy threshold 
during implantation normalize over time, while a third (34%) increases to very high levels. 
Neither ischemic etiology, lead configuration, severely reduced EF nor presence of a scar had 
a significant influence on the future development of energy thresholds. This is in contrast to 
previous  studies,  in  which a  pronounced increase  over time was observed in  particular  in 
patients  with  unipolar  leads  [9]  In  the  latter  study,  only  patients  undergoing  LV  lead 
implantation during 1999-2003 were included, and, consequently, only earlier generation leads 
from two vendors  were used  (Guidant  Easytrak  1 and Medtronic  Attain  2187).  A similar 
increase in LV capture threshold was observed in patients  undergoing CRT during earlier 
years (1994 - 2002) [7,10]. In contrast, the current study included patients from 2003 - 2010 
with  modern,  mainly  bipolar  leads,  with  improved  characteristics  from  all  four  major 
manufacturers, which likely contributed to the more favorable results. The only subgroup to 
demonstrate  an increased likelihood for a high threshold at implantation as well  as during 
follow-up were those  with  a  scar  in  the  inferior,  lateral  or  posterior  region.  Interestingly, 
Biotronik LV leads showed a significant decrease in LV capture thresholds over time, which 
was not observed to this  degree with other manufacturers.  Performance of these particular 
leads has rarely been reported so far, and further studies are warranted to substantiate these 
findings.
Similar to the capture thresholds, high impedance values at implantation normalized in most 
patients (82%) during the ensuing hours to days, and only a minority increased to higher levels 
over time. These findings indicate that in an anatomically optimal position, the mere presence 
of an elevated impedance (i.e., > 1000 Ohm) should not in itself prompt for lead relocation to a 
potentially less suitable LV pacing site. Indeed, no baseline variables including the presence of 
coronary heart disease, lead configuration, and LV scar were predictive of an elevated LV lead 
impedance  at  baseline  or during follow-up. As expected,  LV lead impedance was slightly 
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higher  in  bipolar  leads,  which  did not  change during  follow up.  There  was no difference 
between  the  leads  of  different  manufacturers.                              
A small but significant increase in LV sensing values was observed during follow-up, which 
was most pronounced in patients with non-ischemic cardiomyopathy, bipolar leads, and better 
(> 30%) LV ejection fraction. In contrast, and as expected, R-wave sensing decreased in the 
case  of  scar  tissue  in  the  target  area  of  LV  lead  implantation  (lateral  or  posterior  wall 
segments). In CRT, LV sensing is considered of minor value, as ventricular sensing is usually 
performed via the right ventricular electrode, in particular in CRT-ICD devices. However, our 
data on the development of LV sensing values confirm the overall stable course indicated by 
stable capture thresholds and impedance values of modern LV leads, potentially providing an 
option as  primary pacing leads  (instead of an RV lead  e.g.  in  patients  with reconstructed 
tricuspid  valve  or  bioprosthesis).                                     
In  contrast  to  right  ventricular  pacing  leads,  LV  leads  typically  do  not  have  a  fixation 
mechanism  (screw/tines)  but  are  passively  held  in  place  making  them  more  prone  to 
dislocation, which may result in alterations in pacing parameters. In general, elevated pacing 
thresholds  result  in  faster  battery  depletion,  leading to  more  frequent  device  replacements 
(associated  with  potential  peri-interventional  risks)  as  well  as  increased  costs.  While  the 
limited  amount  of  patients  with very long-term follow-up (i.e.  until  the time of generator 
exchange) precluded a meaningful and comprehensive analysis in this regard, elevated LV 
thresholds will likely be associated with earlier battery depletion also in our cohort. Overall, 
only 7 lead dislocations (3.6%) were observed during the follow-up in our cohort (6 of which 
necessitated  lead  revision),comparable  to  the  recent  Euroheart  Survey,  highlighting  the 
excellent  stability,  performance and safety  of  today's  LV leads  [14]  In one  case a  micro-
dislocation leading to considerably elevated stimulation thresholds was observed, which was 
managed  conservatively.                                    
Our study is limited by its retrospective design; as such, capture thresholds were measured at 
varying pulse width, for which we corrected by calculation of stimulation energy thresholds. 
Although this may render direct transferability of our data difficult,  it represented the only 
valid way to account for these inherent differences. Further limitations include the fact that 
leads from one vendor (Guidant / Boston Scientific) were only used in a minority of patients.  
Conclusions
The current comprehensive analysis of the long-term performance of modern coronary sinus 
leads revealed a stable course of these leads over time. An elevated energy capture threshold at 
implantation was associated with an increased likelihood of proceeding to very high thresholds 
during follow-up, which was the case in 34% of these patients. These data may have important 
implications  for  physicians  involved  in  biventricular  pacemaker  implantations  and  in  the 
follow-up  care  of  these  patients.                                           
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